EYE TECH CARE, based in Lyon, was founded in 2008 by experts in the field of therapeutic ultrasound. The company develops and markets medical devices for the non invasive treatment of eye diseases.
Glaucoma and ocular hypertension affect some 12O million people around the world, but are diagnosed in only about 30% of cases. It is the second cause of blindness, according to WHO (World Health Organization).
With the support of renowned scientific and financial partners, EYE TECH CARE has developed the EyeOP1, an unique therapeutic device. Its teams have designed the only medical procedure that currently addresses all patients with uncontrolled glaucoma, irrespective of their prior treatment history.
Glaucoma and ocular hypertension affect some 12O million people around the world, but are diagnosed in only about 30% of cases. It is the second cause of blindness, according to WHO (World Health Organization).
With the support of renowned scientific and financial partners, EYE TECH CARE has developed the EyeOP1, an unique therapeutic device. Its teams have designed the only medical procedure that currently addresses all patients with uncontrolled glaucoma, irrespective of their prior treatment history.
Location: France, Auvergne-Rhône-Alpes, Rillieux-la-Pape
Employees: 11-50
Total raised: $49.56M
Founded date: 2008
Investors 2
| Date | Name | Website |
| 29.03.2022 | Turenne Ca... | turennecap... |
| - | Omnes Capi... | omnescapit... |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 13.01.2016 | - | $27.13M | - |
| 12.03.2013 | - | $13.02M | - |
| 05.07.2010 | - | $9.4M | - |
Mentions in press and media 6
| Date | Title | Description |
| 12.01.2016 | Daily funding roundup - January 12, 2016 | Skyscanner picked up $192M investments; Datadog raised $94.5M; Elastifile landed $35M funding Gravit, a Berlin, Germany-based online vector design tool, raised a six digit seed funding. German investor High-Tech Gründerfonds (HTGF) made the... |
| 12.01.2016 | Eye Tech Care Secures €25M in Funding | Eye Tech Care SA, a Lyon, France-based company developing and marketing equipment for non-invasive glaucoma treatment in ophthalmology, secured €25m in a new round of funding. Chinese investor Everpine Capital will make the investment in tw... |
| 25.06.2014 | Medtronic taps strategy exec to lead Covidien integration | Personnel Moves | Medtronic (NYSE:MDT) said yesterday that Geoff Martha, senior vice president for strategy & business development, is being promoted to chief integration officer ahead of Medtronic’s $43 billion acquisition of Covidien (NYSE:COV). In a J... |
| 13.03.2013 | EyeTechCare raises $13M for ultrasound glaucoma treatment | EyeTechCare said it landed nearly $13 million in its 3rd round of funding, aiming to use the cash to fund a clinical trial of its EyeOP1 ultrasound glaucoma treatment, which has been on the market in Europe since Rillieux-la-Pape, France-ba... |
| 12.03.2013 | EyeTechCare Secures €10M Third Funding Round | EyeTechCare SA, a Rillieux-la-Pape, near Lyon, France-based developer of non-invasive therapeutic medical devices for the ophthalmology market based on the use of ultrasound, secured a €10m third round of funding. Backers included private i... |
| 05.07.2010 | EyeTechCare Raises €7.5M in Second Round of Funding | EyeTechCare SA, a Rillieux la Pape, France-based developer of non-invasive therapeutic medical devices using ultrasound technology, has raised €7,5m in a second round of funding. Investors include Lyon-based insurance company SHAM, a first ... |